Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma.

Fiche du document

Auteurs
Type de document
Périmètre
Langue
Identifiants
Source

Serveur académique Lausannois

Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.15252/emmm.201707814

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/28923827

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1757-4684

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_ABF970C7CD174

Collection

Serveur Académique Lausannois

Organisation

Université de Lausanne et CHUV

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer

Mots-clés 0

Carcinoma, Hepatocellular/metabolism; Carcinoma, Hepatocellular/pathology; Cell Line, Tumor; Child; Fetus/metabolism; Gluconeogenesis/genetics; Glucose Transporter Type 3/metabolism; Glycolysis/genetics; Hepatoblastoma/metabolism; Hepatoblastoma/pathology; Hexokinase/antagonists & inhibitors; Hexokinase/genetics; Hexokinase/metabolism; Humans; Liver Neoplasms/metabolism; Liver Neoplasms/pathology; Mutation; Proto-Oncogene Proteins c-myc/antagonists & inhibitors; Proto-Oncogene Proteins c-myc/genetics; Proto-Oncogene Proteins c-myc/metabolism; RNA Interference; RNA, Small Interfering/metabolism; Transcription Factor 4/genetics; Transcription Factor 4/metabolism; beta Catenin/antagonists & inhibitors; beta Catenin/genetics; beta Catenin/metabolism; glucose transporter; glycolysis; mutant β‐catenin; pediatric liver cancer

Sujets proches En

Carcinoma Cancers Malignancy (Cancer) Malignant tumors

Citer ce document

S. Crippa et al., « Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma. », Serveur académique Lausannois, ID : 10.15252/emmm.201707814

Métriques

Partage / Export

Résumé 0

Hepatoblastoma is the most common malignant pediatric liver cancer. Histological evaluation of tumor biopsies is used to distinguish among the different subtypes of hepatoblastoma, with fetal and embryonal representing the two main epithelial components. With frequent CTNNB1 mutations, hepatoblastoma is a Wnt/β-catenin-driven malignancy. Considering that Wnt activation has been associated with tumor metabolic reprogramming, we characterized the metabolic profile of cells from hepatoblastoma and compared it to cells from hepatocellular carcinoma. First, we demonstrated that glucose transporter GLUT3 is a direct TCF4/β-catenin target gene. RNA sequencing enabled to identify molecular and metabolic features specific to hepatoblastoma and revealed that several glycolytic enzymes are overexpressed in embryonal-like compared to fetal-like tumor cells. This led us to implement successfully three biomarkers to distinguish embryonal from fetal components by immunohistochemistry from a large panel of human hepatoblastoma samples. Functional analyses demonstrated that embryonal-like hepatoblastoma cells are highly glycolytic and sensitive to hexokinase-1 silencing. Altogether, our findings reveal a new, metabolic classification of human hepatoblastoma, with potential future implications for patients' diagnosis and treatment.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en